Rupert Haynes

Corporate Officer/Principal en RADIUS HEALTH, INC. .

Health Technology

Perfil

Rupert Haynes is currently the Head-Global Strategy at Radius Health, Inc. He was previously the Chief Executive Officer at FSD Pharma, Inc. from 2018 to 2019.
Prior to that, he held positions as Director-Global Marketing at GW Pharmaceuticals Ltd.
and Head-Global Commercial Operations at Swedish Orphan Biovitrum AB.

Cargos activos de Rupert Haynes

Empresas	Cargo	Inicio
RADIUS HEALTH, INC.	Corporate Officer/Principal	01/02/2021

Todos los cargos activos de Rupert Haynes

Antiguos cargos conocidos de Rupert Haynes.

Empresas	Cargo	Fin
FSD PHARMA INC.	Chief Executive Officer	06/02/2019
GW PHARMACEUTICALS PLC	Sales & Marketing	-
SWEDISH ORPHAN BIOVITRUM AB	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Rupert Haynes.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Rupert Haynes.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
SWEDISH ORPHAN BIOVITRUM AB	Health Technology
FSD PHARMA INC.	Health Technology

Empresas privadas	2
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.	Health Technology
GW Pharmaceuticals Ltd. GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.	Health Technology